TAT-phiC31 integrase mediates DNA recombination in mammalian cells

Journal of Biotechnology

Volumn 142, Issue 2, 2009, Pages 107-113

  Zhang, Mao xiang ^a   Li, Zhi hui ^a   Fang, Yu xiang ^a   Zhu, Huan zhang ^a   Xue, Jing lun ^a   Chen, Jin zhong ^a   Jia, William ^a,b  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Gene therapy; Integrase; Mammalian cells; phiC31; Protein transduction; TAT

Indexed keywords

GENE THERAPY; INTEGRASE; MAMMALIAN CELLS; PHIC31; PROTEIN TRANSDUCTION; TAT;

AMINES; BACTERIOPHAGES; CELL CULTURE; GENE TRANSFER; MAMMALS; NUCLEIC ACIDS; TOXICITY;

CELL MEMBRANES;

INTEGRASE; PROTEIN PHIC31; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DNA INTEGRATION; DNA RECOMBINATION; ENZYME LOCALIZATION; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

BACTERIOPHAGES; BASE SEQUENCE; CELL LINE; DATA INTERPRETATION, STATISTICAL; GENE THERAPY; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRASES; MOLECULAR SEQUENCE DATA; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; RECOMBINATION, GENETIC; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSFECTION;

MAMMALIA; STREPTOMYCES;

EID: 67349251206     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2009.03.018     Document Type: Article

References (35)

1. Andress S., Schwenk F., Kuter-Luke B., Faust N., and Kuhn R. Enhanced efficiency through nuclear localization signal fusion on phage phiC31-integrase: activity comparison with Cre and FLPe recombinase in mammalian cells. Nucleic Acids Res. 30 (2002) 2299-2306
2. Belteki G., Gertsenstein M., Ow D.W., and Nagy A. Site-specific cassette exchange and germline transmission with mouse ES cells expressing phiC31 integrase. Nat. Biotechnol. 21 (2003) 321-324
3. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72 (1976) 248-254
4. Chen J., Ji C., Xu G., Pang R., Yao J., Zhu H., Xue J., and William J. DAXX interacts with phiC31 integrase and inhibits recombination. Nucleic Acids Res. 34 (2006) 6298-6304
5. Diaz V., Rojo F., Martinez A.C., Alonso J.C., and Bernad A. The prokaryotic beta-recombinase catalyses site-specific recombination in mammalian cells. J. Biol. Chem. 274 (1999) 6634-6640
6. Fawell S., Seery J., Daikh Y., Moore C., Chen L.L., Pepinsky B., and Barsoum J. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 664-668
7. Feng Y.Q., Seibler J., Alami R., Eisen A., Westerman K.A., Leboulch P., Fiering S., and Bouhassira E.E. Site-specific chromosomal integration in mammalian cells: highly efficient CRE recombinase-mediated cassette exchange. J. Mol. Biol. 292 (1999) 779-785
8. Groth A.C., Olivares E.C., Thyagarajan B., and Calos M.P. A phage integrase directs efficient site-specific integration in human cells. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 5995-6000
9. Hacein-Bey-Abina S., Von Kalle C., Schmidt M., Le Deist F., Wulffraat N., McIntyre E., Radford I., Villeval J.L., Fraser C.C., Cavazzana-Calvo M., and Fischer A. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348 (2003) 255-256
10. Hacein-Bey-Abina S., Von Kalle C., Schmidt M., McCormack M.P., et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302 (2003) 415-419
11. Ho A., Schwarze S.R., Mermelstein S.J., Waksman G., and Dowdy S.F. Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res. 61 (2001) 474-477
12. Hollis R.P., Stoll S.M., Sclimenti C.R., Lin J., Chen-Tsai Y., and Calos M.P. Phage integrases for the construction and manipulation of transgenic mammals. Reprod. Biol. Endocrinol. 1 (2003) 79-84
13. Kolot M., Silberstein N., and Yagil E. Site-specific recombination in mammalian cells expressing the Int recombinase of bacteriophage HK022. Mol. Biol. Rep. 26 (1999) 207-213
14. Li Z., Dullmann J., Schiedlmeier B., Schmidt M., et al. Murine leukemia induced by retroviral gene marking. Science 296 (2002) 497
15. Merrihew R.V., Sargent R.G., and Wilson J.H. Efficient modification of the APRT gene by FLP/FRT site-specific targeting. Somat. Cell Mol. Genet. 21 (1995) 299-307
16. Nagahara H., Vocero-Akbani A.M., Snyder E.L., Ho A., Latham D.G., Lissy N.A., Becker-Hapak M., Ezhevsk S.A., and Dowdy S.F. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat. Med. 4 (1998) 1449-1452
17. Olivares E.C., Hollis R.P., Chalberg T.W., Meuse L., Kay M.A., and Calos M.P. Site-specific genomic integration produces therapeutic Factor IX levels in mice. Nat. Biotechnol. 20 (2002) 1124-1128
18. Ortiz-Urda S., Thyagarajan B., Keene D.R., Lin Q., Calos M.P., and Khavari P.A. phiC31 integrase mediated nonviral genetic correction of junctional epidermolysis bullosa. Hum. Gene Ther. 14 (2003) 923-928
19. Qiagen Inc. A Handbook for High-Level Expression and Purification of 6His-Tagged Proteins. fifth ed. (2003), The QIAexpressionist™ pp. 85-95
20. Rinaudo D., Lamartina S., Roscilli G., Ciliberto G., and Toniatti C. Conditional site-specific integration into human chromosome 19 by using a ligand-dependent chimeric adeno-associated virus/Rep protein. J. Virol. 74 (2000) 281-294
21. Sarkis G.J., Murley L.L., Leschziner A.E., Boocock M.R., Stark W.M., and Grindley N.D.F. A model for the gamma delta resolvase synaptic complex. Mol. Cell. 8 (2001) 623-631
22. Sauer B., and Henderson N. Cre-stimulated recombination at loxP-containing DNA sequences placed into the mammalian genome. Nucleic Acids Res. 17 (1989) 147-161
23. Sauer B., and Henderson N. Targeted insertion of exogenous DNA into the eukaryotic genome by the Cre recombinase. N. Biol. 2 (1990) 441-449
24. Sauer B. Site-specific recombination: developments and applications. Curr. Opin. Biotechnol. 5 (1994) 521-527
25. Schroder A.R., Shinn P., Chen H., Berry C., Ecker J.R., and Bushman F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110 (2002) 521-529
26. Schwarze S.R., Hruska K.A., and Dowdy S.F. Protein transduction: unrestricted delivery into all cells?. Trends Cell. Biol. 10 (2000) 290-295
27. Schwikardi M., and Droge P. Site-specific recombination in mammalian cells catalyzed by gamma delta resolvase mutants: implications for the topology of episomal DNA. FEBS Lett. 471 (2000) 147-150
28. Sclimenti C.R., Thyagarajan B., and Calos M.P. Directed evolution of a recombinase for improved genomic integration at a native human sequence. Nucleic Acids Res. 29 (2001) 5044-5051
29. Smith M.C.A., Till R., Brady K., Soultanas P., Thorpe H.M., and Smith M.C.M. Synapsis and DNA cleavage in phiC31 integrase-mediated site-specific recombination. Nucleic Acids Res. 32 (2004) 2607-2617
30. Smith M.C.M., and Thorpe H.M. Diversity in the serine recombinases. Mol. Microbiol. 44 (2002) 299-307
31. Thomason L.C., Calendar R., and Ow D.W. Gene insertion and replacement in Schizosaccharomyces pombe mediated by the Streptomyces bacteriophage phiC31 site-specific recombination system. Mol. Gen. Genom. 265 (2001) 1031-1038
32. Thorpe H.M., and Smith M.C.M. In vitro site-specific integration of bacteriophage DNA catalyzed by a recombinase of the resolvase/invertase family. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 5505-5510
33. Thorpe H.M., Wilson S.E., and Smith M.C. Control of directionality in the site-specific recombination system of the Streptomyces phage phiC31. Mol. Microbiol. 38 (2000) 232-241
34. Thyagarajan B., Olivares E.C., Hollis R.P., Ginsburg D.S., and Calos M.P. Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase. Mol. Cell. Biol. 21 (2001) 3926-3934
35. Young Jr. S.M., McCarty D.M., Degtyareva N., and Samulski R.J. Roles of adeno-associated virus Rep protein and human chromosome 19 in site-specific recombination. J. Virol. 74 (2000) 3953-3966